{"id":487,"date":"2024-07-06T17:14:31","date_gmt":"2024-07-06T17:14:31","guid":{"rendered":"https:\/\/coloradesign.com\/cardio\/?post_type=research-study&#038;p=487"},"modified":"2024-07-06T17:24:17","modified_gmt":"2024-07-06T17:24:17","slug":"redual","status":"publish","type":"research-study","link":"https:\/\/coloradesign.com\/cardio\/research-study\/redual\/","title":{"rendered":"REDUAL"},"content":{"rendered":"\n<p>The main objective of this study is to compare a Dual Antithrombotic Therapy (DAT) regimen of 110mg dabigatran etexilate b.i.d. plus clopidogrel or ticagrelor (110mg dabigatran etexilate (DE) DAT) and 150mg dabigatran etexilate b.i.d. plus clopidogrel or ticagrelor (150mg DE-DAT) with a Triple Antithrombotic Therapy (TAT) combination of warfarin plus clopidogrel or ticagrelor plus Aspirin (ASA) &lt;= 100mg once daily (warfarin-TAT) in patients with Atrial Fibrillation that undergo a PCI with stenting (elective or due to an Acute Coronary Syndrome).<\/p>\n\n\n<p>[button title=&#8221;Read Study&#8221; link=&#8221;https:\/\/clinicaltrials.gov\/study\/NCT02164864&#8243; target=&#8221;_blank&#8221; align=&#8221;&#8221; icon=&#8221;&#8221; icon_position=&#8221;&#8221; color=&#8221;&#8221; font_color=&#8221;&#8221; size=&#8221;2&#8243; full_width=&#8221;&#8221; class=&#8221;&#8221; download=&#8221;&#8221; rel=&#8221;&#8221;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The main objective of this study is to compare a Dual Antithrombotic Therapy (DAT) regimen of 110mg dabigatran etexilate b.i.d. plus clopidogrel or ticagrelor (110mg dabigatran etexilate (DE) DAT) and 150mg dabigatran etexilate b.i.d. plus clopidogrel or ticagrelor (150mg DE-DAT) with a Triple Antithrombotic Therapy (TAT) combination of warfarin plus clopidogrel or ticagrelor plus Aspirin &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/coloradesign.com\/cardio\/research-study\/redual\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;REDUAL&#8221;<\/span><\/a><\/p>\n","protected":false},"featured_media":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"study-category":[21],"class_list":["post-487","research-study","type-research-study","status-publish","format-standard","hentry","study-category-atrial-fibrillation-anticoagulation","entry"],"acf":[],"_links":{"self":[{"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/research-study\/487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/research-study"}],"about":[{"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/types\/research-study"}],"version-history":[{"count":1,"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/research-study\/487\/revisions"}],"predecessor-version":[{"id":488,"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/research-study\/487\/revisions\/488"}],"wp:attachment":[{"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/media?parent=487"}],"wp:term":[{"taxonomy":"study-category","embeddable":true,"href":"https:\/\/coloradesign.com\/cardio\/wp-json\/wp\/v2\/study-category?post=487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}